SCHEMBL1126378

SCHEMBL1126378

COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3nccn3CN3CCOCC3)c3nccnc23)c1F

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126274 0.93 FGFR3 (0.66) FGFR3
SCHEMBL1126311 0.83 FGFR3 (0.64) FGFR3
SCHEMBL1126540 0.82 FGFR3 (0.58) FGFR3
SCHEMBL1126379 0.79 FGFR3 (0.74) FGFR3
SCHEMBL1126456 0.79 FGFR3 (0.65) FGFR3
SCHEMBL1126209 0.74 FGFR3 (0.84) FGFR3
SCHEMBL1126269 0.74 FGFR3 (1.00) FGFR3
SCHEMBL1126558 0.73 FGFR3 (1.00) FGFR3
SCHEMBL1126181 0.73 FGFR3 (0.72) FGFR3
SCHEMBL1126840 0.73 FGFR3 (1.00) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP disclosed